v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Income Statement [Abstract]        
Net sales $ 7,685 $ 6,886 $ 15,037 $ 13,530
Cost of goods sold 5,470 4,981 10,981 9,801
Gross profit 2,215 1,905 4,056 3,729
Operating expense        
Selling, general and administrative expenses 1,295 1,073 2,523 2,143
Amortization of intangible assets 177 176 353 351
Other operating expenses 348 14 363 22
Total operating expense 1,820 1,263 3,239 2,516
Operating income 395 642 817 1,213
Other expense        
Interest expense, net (119) (223) (255) (433)
Other loss, net (42) 0 (41) 0
Foreign exchange gain (loss), net 1 (60) 5 (83)
Total other expense (160) (283) (291) (516)
Income before income taxes 235 359 526 697
Provision for income taxes 96 26 148 42
Net income 139 333 378 655
Net income attributable to noncontrolling interests 79 0 189 0
Net income attributable to Medline Inc. $ 60 333 $ 189 655
Earnings per share attributable to Medline Inc.        
Basic (in dollars per share) $ 0.07   $ 0.23  
Diluted (in dollars per share) $ 0.07   $ 0.23  
Weighted-average number of Class A common stock outstanding        
Basic (in shares) 856,671,262   838,299,245  
Diluted (in shares) 860,890,719   842,879,656  
Other comprehensive (loss) income, net of tax        
Net unrealized loss on derivative instruments $ (9) (20) $ (12) (50)
Currency translation adjustment (28) 75 (39) 101
Total other comprehensive (loss) income, net of tax (37) 55 (51) 51
Total comprehensive income 102 388 327 706
Comprehensive income attributable to noncontrolling interests 66 0 171 0
Comprehensive income attributable to Medline Inc. $ 36 $ 388 $ 156 $ 706